Trial intelligence / Profile preview

Phase II dasatinib in pediatric Philadelphia chromosome-positive leukemias

NL-OMON47600Phase 2Active, not recruiting

Sponsor

Bristol Myers Squibb

Start

Nov 2011

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1